David Einhorn Gain Therapeutics, Inc. Put Options Transaction History
Greenlight Capital Inc
- $1.97 Billion
- Q4 2023
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GANX
# of Institutions
25Shares Held
2.46MCall Options Held
10KPut Options Held
0-
Dme Capital Management, LP New York, NY566KShares$1.47 Million0.04% of portfolio
-
Joel Greenblatt Gotham Asset Management, LLC | New York, Ny335KShares$866,5930.01% of portfolio
-
Geode Capital Management, LLC Boston, MA272KShares$704,4070.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA145KShares$376,1120.0% of portfolio
-
Telemetry Investments, L.L.C. New York, NY123KShares$318,5700.61% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $30.8M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...